NCT02022176
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Karolinska Institutet Stockholm, Sweden
Clinical trial condition
Insulin Resistance
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
2,345 public trials
206 recruiting studies
Insulin Resistance trial results
Completed
GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes
NCT00509223
- Conditions
- Apnea, Diabetes Mellitus, Diabetes Mellitus Type 2, +15 more
- Locations
-
- Mission Internal Medical Group Mission Viejo, California, United States
- Advanced Metabolic Care and Research Institute Temecula, California, United States
- Clinical Research of South Florida Coral Gables, Florida, United States
- SleepMed of Central Georgia Macon, Georgia, United States
NCT01573377
- Conditions
- Adnexal Diseases, Cysts, Endocrine System Diseases, +15 more
- Locations
-
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
NCT01847456
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- University of Tuebingen, Internal medicine IV Tübingen, Germany
Completed
A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus
NCT01175811
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
- Conditions
- Glucose Metabolism Disorders, Healthy Subjects, Hyperinsulinism, +3 more
- Locations
-
- PACT Pulmonary Associates Phoenix, Arizona, United States
Completed
Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans
NCT00422253
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
- Locations
-
- Baker Heart Research Insitute Melbourne, Victoria, Australia
NCT01412645
- Conditions
- Body Weight, Bone Diseases, Bone Diseases, Metabolic, +17 more
- Locations
-
- Clinical Institute, Aarhus University Aarhus, Denmark
NCT02011217
- Conditions
- Appetite Regulation, Glucose Metabolism Disorders, Hyperinsulinism, +3 more
- Locations
-
- Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Uppsala County, Sweden
NCT02006394
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +12 more
- Locations
-
- University of California, San Diego San Diego, California, United States